Title
Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma
A 12-week, Randomized, Parallel-group, Phase III Study Comparing the Efficacy of Once-daily Budesonide/Formoterol Turbuhaler (160/4.5 μg/d) and Twice-daily Budesonide Giona Easyhaler (400 μg/d) During Step-down Period in Well Controlled Asthma
Phase
Phase 3Lead Sponsor
Hat Yai Medical Education CenterStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
AsthmaIntervention/Treatment
formoterol budesonide ...Study Participants
77This study will evaluate the efficacy of Once-daily Budesonide/formoterol Turbuhaler 160/4.5 µg/d in the period of step down in well controlled asthmatic patient.
The study will measure the efficacy of once daily low dose ICS/ LABA in well controlled asthmatic patient comparing with low dose ICS in step down circumstance.
After the patients who have all criteria, they will be randomization to take Budesonide/formoterol (160/4.5 μg/d)
After the patients who have all criteria, they will be randomization to take Budesonide (200 ug) twice daily
once-daily budesonide/formoterol (160/4.5 μg/d)
twice-daily Budesonide (400μg/d)
Inclusion Criteria: Asthmatic patients who have well controlled asthma at least 12 weeks with using budesonide/formoterol (160/4.5 μg/d) twice daily Age more than 18 year-old Patients who able to do spirometry without contraindication History smoking less than 10 pack-years Exclusion Criteria: History of using systemic steroid previous 4 week and respiratory infection History of pulmonary tuberculosis with residual lung lesion by chest radiograph recent serious medical condition such as myocardial infarction, stroke, pneumonia etc.